217 related articles for article (PubMed ID: 28148846)
1. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
Bagó JR; Okolie O; Dumitru R; Ewend MG; Parker JS; Werff RV; Underhill TM; Schmid RS; Miller CR; Hingtgen SD
Sci Transl Med; 2017 Feb; 9(375):. PubMed ID: 28148846
[TBL] [Abstract][Full Text] [Related]
2. Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients.
Buckley A; Hagler SB; Lettry V; Bagó JR; Maingi SM; Khagi S; Ewend MG; Miller CR; Hingtgen SD
Mol Ther; 2020 Jul; 28(7):1614-1627. PubMed ID: 32402245
[TBL] [Abstract][Full Text] [Related]
3. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
[TBL] [Abstract][Full Text] [Related]
4. Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
Okolie O; Irvin DM; Bago JR; Sheets K; Satterlee A; Carey-Ewend AG; Lettry V; Dumitru R; Elton S; Ewend MG; Miller CR; Hingtgen SD
PLoS One; 2018; 13(7):e0198596. PubMed ID: 29990322
[TBL] [Abstract][Full Text] [Related]
5. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
[TBL] [Abstract][Full Text] [Related]
6. Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.
Bagó JR; Pegna GJ; Okolie O; Hingtgen SD
Biomaterials; 2016 Apr; 84():42-53. PubMed ID: 26803410
[TBL] [Abstract][Full Text] [Related]
7. Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.
Satterlee AB; Dunn DE; Lo DC; Khagi S; Hingtgen S
Neuro Oncol; 2019 Dec; 21(12):1552-1564. PubMed ID: 31420675
[TBL] [Abstract][Full Text] [Related]
8. Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.
Bagó JR; Alfonso-Pecchio A; Okolie O; Dumitru R; Rinkenbaugh A; Baldwin AS; Miller CR; Magness ST; Hingtgen SD
Nat Commun; 2016 Feb; 7():10593. PubMed ID: 26830441
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
[TBL] [Abstract][Full Text] [Related]
10. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
Redjal N; Zhu Y; Shah K
Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100
[TBL] [Abstract][Full Text] [Related]
11. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
Bagó JR; Pegna GJ; Okolie O; Mohiti-Asli M; Loboa EG; Hingtgen SD
Biomaterials; 2016 Jun; 90():116-25. PubMed ID: 27016620
[TBL] [Abstract][Full Text] [Related]
12. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2020 Oct; ():. PubMed ID: 33085922
[TBL] [Abstract][Full Text] [Related]
13. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.
Kauer TM; Figueiredo JL; Hingtgen S; Shah K
Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831
[TBL] [Abstract][Full Text] [Related]
14. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.
van de Water JA; Bagci-Onder T; Agarwal AS; Wakimoto H; Roovers RC; Zhu Y; Kasmieh R; Bhere D; Van Bergen en Henegouwen PM; Shah K
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16642-7. PubMed ID: 23012408
[TBL] [Abstract][Full Text] [Related]
16. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
[TBL] [Abstract][Full Text] [Related]
17. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma.
Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T
Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058
[TBL] [Abstract][Full Text] [Related]
18. Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy.
Teng J; Hejazi S; Badr CE; Tannous BA
Stem Cells; 2014 Aug; 32(8):2021-32. PubMed ID: 24801379
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal analysis of induced neural stem cell therapy to overcome advanced glioblastoma recurrence.
Satterlee AB; Dunn DE; Valdivia A; Malawsky D; Buckley A; Gershon T; Floyd S; Hingtgen S
Mol Ther Oncolytics; 2022 Sep; 26():49-62. PubMed ID: 35784402
[TBL] [Abstract][Full Text] [Related]
20. Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity.
Moore KM; Graham-Gurysh EG; Bomba HN; Murthy AB; Bachelder EM; Hingtgen SD; Ainslie KM
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110846. PubMed ID: 32279815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
